Braingaze
Digitalize diagnosis and treatment for cognitive disorders
Braingaze is active in the ai machine learning space based in Spain, founded in 2013.
Profile
Cognitive disorders with dementia alone causing US$680b in global economic impact. Braingaze offers a patented, scientifically and clinically validated biomarker-based decision support system for early diagnosis of dementia and Alzheimer’s and a game based digital treatment that improves patients’ cognitive health.
Its activity falls under ai machine learning; the profile below is assembled from public directory data.
Its base of operations is Spain.
It is recorded at the SOSV portfolio company stage.
The company reports a headcount in the 2-10 range.
It has disclosed roughly $1M in funding.
| Sector | Ai Machine Learning |
|---|---|
| Country | Spain |
| Founded | 2013 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $1,000,000 |
Website: braingaze.com
Create a free account